Nostrum Laboratories – Recall of metformin extended-release (ER)
January 4, 2021 - Nostrum announced a voluntary, consumer level recall of one lot of metformin 750 mg ER tablets due to contamination with n-nitrosodimethylamine (NDMA) above the acceptable daily intake (ADI) limit of 96 ng/day. This is an expansion of the recall initially announced on November 2, 2020.
Top